Evaluation and Treatment of Patients With Inherited Eye Diseases
Hereditary Eye Disease
About this trial
This is an observational trial for Hereditary Eye Disease focused on measuring Evaluation and Treatment, Ophthalmic Genetic Diseases, Genetic Testing, Genetic Eye Diseases, Evaluation
Eligibility Criteria
INCLUSION CRITERIA: Patients are initially screened for NEI protocols under the NEI screening protocol or from closeout of another protocol. Some of these patients will have a genetic eye disease that NEI staff wishes to follow and treat. Such patients can then be enrolled in this evaluation and treatment protocol. Each study participant must have the ability to understand and sign an informed consent form. EXCLUSION CRITERIA: Patients will be excluded from this study if they are unable or unwilling to give informed consent or they are unwilling to be followed and treated at the NEI clinical center for at least the next 3 years.
Sites / Locations
- National Institutes of Health Clinical Center, 9000 Rockville Pike